Indaptus Therapeutics, Inc. Annual Depreciation in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Indaptus Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2020 to 2023.
  • Indaptus Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $735.000, a 129% increase year-over-year.
  • Indaptus Therapeutics, Inc. annual Depreciation for 2023 was $1.28K, a 27.9% decline from 2022.
  • Indaptus Therapeutics, Inc. annual Depreciation for 2022 was $1.78K, a 26.9% increase from 2021.
  • Indaptus Therapeutics, Inc. annual Depreciation for 2021 was $1.4K, a 64.7% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.28K -$497 -27.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-13
2022 $1.78K +$378 +26.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 $1.4K +$551 +64.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-17
2020 $852 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.